Ghent University Academic Bibliography

Your filters: cql: author="Van Nieuwenhuysen, Els" or (type any "bookEditor issueEditor" and editor="Van Nieuwenhuys...

Add to list
- Journal Article
- A1
- open access
A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer : ALEPRO trial

Tine Ottenbourgs, Toon van Gorp, Frédéric Kridelka, Thaïs Baert, Hannelore Denys (UGent) , Frédéric Selle, Inge Baas (UGent) , Anne-Sophie Van Rompuy, Diether Lambrechts and Els Van Nieuwenhuysen

(2024) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 34(4). p.627-630
Add to list
- Journal Article
- A1
- open access
Tisotumab vedotin in combination with carboplatin, pembrolizumab, or bevacizumab in recurrent or metastatic cervical cancer : results from the innovaTV 205/GOG-3024/ENGOT-cx8 study

Ignace Vergote, Els Van Nieuwenhuysen, Roisin E. O'Cearbhaill, Anneke Westermann, Domenica Lorusso, Sharad Ghamande, Dearbhaile C. Collins, Susana Banerjee, Cara A. Mathews, Christine Gennigens, et al.

(2023) JOURNAL OF CLINICAL ONCOLOGY. 41(36). p.5536-5549
Add to list
- Journal Article
- A1
- open access
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma : an ovarian tumor tissue analysis consortium study

Eun-Young Kang, Ashley Weir, Nicola S Meagher, Kyo Farrington, Gregg S Nelson, Prafull Ghatage, Cheng-Han Lee, Marjorie J Riggan, Adelyn Bolithon, Gordana Popovic, et al.

(2023) CANCER. 129(5). p.697-713
Add to list
- Journal Article
- A1
Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer

Adriaan Vanderstichele, Liselore Loverix, Pieter Busschaert, Els Van Nieuwenhuysen, Sileny N. Han, Nicole Concin, Tiene Callewaert, Siel Olbrecht, Rawand Salihi (UGent) , Patrick Berteloot, et al.

(2022) GYNECOLOGIC ONCOLOGY. 165(1). p.14-22
Add to list
Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer : a study of the Belgian and Luxembourg Gynaecological Oncology Group

Ignace Vergote, Els Van Nieuwenhuysen, Stefanie De Waele, Christof Vulsteke, Caroline Lamot, Heidi Van den Bulck, Nele Claes, Marie-Pascale Graas, Guy Debrock, Isabelle Spoormans, et al.

(2022) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 32(6). p.753-760
Add to list
- Journal Article
- A1
- open access
Polygenic risk modeling for prediction of epithelial ovarian cancer risk

Eileen O. Dareng, Jonathan P. Tyrer, Daniel R. Barnes, Michelle R. Jones, Xin Yang, Katja K. H. Aben, Muriel A. Adank, Simona Agata, Irene L. Andrulis, Hoda Anton-Culver, et al.

(2022) EUROPEAN JOURNAL OF HUMAN GENETICS. 30(3). p.349-362
Add to list
- Journal Article
- A1
Experience with PlasmaJet™ in debulking surgery in 87 patients with advanced‐stage ovarian cancer

Alexander Volcke, Els Van Nieuwenhuysen, Sileny Han, Rawand Salihi (UGent) , Toon Van Gorp and Ignace Vergote

(2021) JOURNAL OF SURGICAL ONCOLOGY. 123(4). p.1109-1114
Add to list
- Journal Article
- A1
Combination of weekly paclitaxel-carboplatin plus standard bevacizumab as neoadjuvant treatment in stage IB–IIB cervical cancer

Charlotte Maene, Rawand Salihi (UGent) , Els Van Nieuwenhuysen, Sileny N Han, Nicole Concin and Ignace Vergote

(2021) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 31(6). p.824-828
Add to list
- Journal Article
- A1
Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria

Jolien Haesen, Rawand Salihi (UGent) , Toon Van Gorp, Els Van Nieuwenhuysen, Sileny N. Han, Melissa Christiaens, Anne-Sophie Van Rompuy, Lise Waumans, Patrick Neven and Ignace Vergote

(2021) GYNECOLOGIC ONCOLOGY. 162(3). p.539-545
Add to list
- Journal Article
- A1
Para-aortic lymph node surgical staging in locally-advanced cervical cancer : comparison between robotic versus conventional laparoscopy

Liselore Loverix, Rawand Salihi (UGent) , Els Van Nieuwenhuysen, Nicole Concin, Sileny Han, Toon van Gorp and Ignace Vergote

(2020) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 30(4). p.466-472

Academic Bibliography

A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer : ALEPRO trial

Tisotumab vedotin in combination with carboplatin, pembrolizumab, or bevacizumab in recurrent or metastatic cervical cancer : results from the innovaTV 205/GOG-3024/ENGOT-cx8 study

CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma : an ovarian tumor tissue analysis consortium study

Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer

Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer : a study of the Belgian and Luxembourg Gynaecological Oncology Group

Polygenic risk modeling for prediction of epithelial ovarian cancer risk

Experience with PlasmaJet™ in debulking surgery in 87 patients with advanced‐stage ovarian cancer

Combination of weekly paclitaxel-carboplatin plus standard bevacizumab as neoadjuvant treatment in stage IB–IIB cervical cancer

Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria

Para-aortic lymph node surgical staging in locally-advanced cervical cancer : comparison between robotic versus conventional laparoscopy

Contents

Support

Contact